|
1
|
Ottaviani G and Jaffe N: The epidemiology
of osteosarcoma. Cancer Treat Res. 152:3–13. 2009. View Article : Google Scholar
|
|
2
|
Wittig JC, Bickels J, Priebat D, et al:
Osteosarcoma: a multidisciplinary approach to diagnosis and
treatment. Am Fam Physician. 65:1123–1132. 2002.PubMed/NCBI
|
|
3
|
Rosen G, Caparros B, Groshen S, et al:
Primary osteogenic sarcoma of the femur: a model for the use of
preoperative chemotherapy in high risk malignant tumors. Cancer
Invest. 2:181–192. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yang ZJ, Chee CE, Huang S and Sinicrope
FA: The role of autophagy in cancer: therapeutic implications. Mol
Cancer Ther. 10:1533–1541. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Provisor AJ, Ettinger LJ, Nachman JB, et
al: Treatment of nonmetastatic osteosarcoma of the extremity with
preoperative and postoperative chemotherapy: a report from the
Children’s Cancer Group. J Clin Oncol. 15:76–84. 1997.
|
|
6
|
Goorin AM, Schwartzentruber DJ, Devidas M,
et al; Pediatric Oncology Group. Presurgical chemotherapy compared
with immediate surgery and adjuvant chemotherapy for nonmetastatic
osteosarcoma: Pediatric Oncology Group Study POG-8651. J Clin
Oncol. 21:1574–1580. 2003. View Article : Google Scholar
|
|
7
|
Huang J, Ni J, Liu K, et al: HMGB1
promotes drug resistance in osteosarcoma. Cancer Res. 72:230–238.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Amaravadi RK, Lippincott-Schwartz J, Yin
XM, et al: Principles and current strategies for targeting
autophagy for cancer treatment. Clin Cancer Res. 17:654–666. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Livesey KM, Tang D, Zeh HJ and Lotze MT:
Autophagy inhibition in combination cancer treatment. Curr Opin
Investig Drugs. 10:1269–1279. 2009.PubMed/NCBI
|
|
10
|
Kang R, Tang D, Schapiro NE, et al: The
receptor for advanced glycation end products (RAGE) sustains
autophagy and limits apoptosis, promoting pancreatic tumor cell
survival. Cell Death Differ. 17:666–676. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mizushima N, Levine B, Cuervo AM and
Klionsky DJ: Autophagy fights disease through cellular
self-digestion. Nature. 451:1069–1075. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
White E and DiPaola RS: The double-edged
sword of autophagy modulation in cancer. Clin Cancer Res.
15:5308–5316. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mathew R, Karantza-Wadsworth V and White
E: Role of autophagy in cancer. Nat Rev Cancer. 7:961–967. 2007.
View Article : Google Scholar
|
|
14
|
Tang D, Kang R, Livesey KM, et al:
Endogenous HMGB1 regulates autophagy. J Cell Biol. 190:881–892.
2010. View Article : Google Scholar
|
|
15
|
Tang D, Kang R, Livesey KM, et al:
High-mobility group box 1 is essential for mitochondrial quality
control. Cell Metab. 13:701–711. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu L, Yang M, Kang R, et al:
HMGB1-induced autophagy promotes chemotherapy resistance in
leukemia cells. Leukemia. 25:23–31. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tang D, Kang R, Cheh CW, et al: HMGB1
release and redox regulates autophagy and apoptosis in cancer
cells. Oncogene. 29:5299–5310. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ambros V: MicroRNA pathways in flies and
worms: growth, death, fat, stress, and timing. Cell. 113:673–676.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Brennecke J, Hipfner DR, Stark A, Russell
RB and Cohen SM: Bantam encodes a developmentally regulated
microRNA that controls cell proliferation and regulates the
proapoptotic gene hid in Drosophila. Cell. 113:25–36. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zou Z, Wu L, Ding H, et al: MicroRNA-30a
sensitizes tumor cells to cis-platinum via suppressing beclin
1-mediated autophagy. J Biol Chem. 287:4148–4156. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hu H, Li S, Cui X, et al: The
overexpression of hypomethylated miR-663 induces chemotherapy
resistance in human breast cancer cells by targeting heparin
sulfate proteoglycan 2 (HSPG2). J Biol Chem. 288:10973–10985. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bourguignon LY, Wong G, Earle C and Chen
L: Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes
miR-302 expression leading to self-renewal, clonal formation, and
cisplatin resistance in cancer stem cells from head and neck
squamous cell carcinoma. J Biol Chem. 287:32800–32824. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kastl L, Brown I and Schofield AC:
miRNA-34a is associated with docetaxel resistance in human breast
cancer cells. Breast Cancer Res Treat. 131:445–454. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tao J, Lu Q, Wu D, et al: microRNA-21
modulates cell proliferation and sensitivity to doxorubicin in
bladder cancer cells. Oncol Rep. 25:1721–1729. 2011.PubMed/NCBI
|
|
25
|
Song B, Wang Y, Xi Y, et al: Mechanism of
chemoresistance mediated by miR-140 in human osteosarcoma and colon
cancer cells. Oncogene. 28:4065–4074. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mukhopadhyay P, Pacher P and Das DK:
MicroRNA signatures of resveratrol in the ischemic heart. Ann NY
Acad Sci. 1215:109–116. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhu H, Wu H, Liu X, et al: Regulation of
autophagy by a beclin 1-targeted microRNA, miR-30a, in cancer
cells. Autophagy. 5:816–823. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Brest P, Lapaquette P, Souidi M, et al: A
synonymous variant in IRGM alters a binding site for miR-196 and
causes deregulation of IRGM-dependent xenophagy in Crohn’s disease.
Nat Genet. 43:242–245. 2011.PubMed/NCBI
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−delta delta C(T)) method. Methods. 25:402–408. 2001.
|
|
30
|
Kim SW, Li Z, Moore PS, et al: A sensitive
non-radioactive northern blot method to detect small RNAs. Nucleic
Acids Res. 38:e982010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Paglin S, Hollister T, Delohery T, et al:
A novel response of cancer cells to radiation involves autophagy
and formation of acidic vesicles. Cancer Res. 61:439–444.
2001.PubMed/NCBI
|
|
32
|
Rebucci M and Michiels C: Molecular
aspects of cancer cell resistance to chemotherapy. Biochemical
Pharmacology. 85:1219–1226. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Rosenfeldt MT and Ryan KM: The multiple
roles of autophagy in cancer. Carcinogenesis. 32:955–963. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
He C and Klionsky DJ: Regulation
mechanisms and signaling pathways ofautophagy. Annu Rev Genet.
43:67–93. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xie Z and Klionsky DJ: Autophagosome
formation: core machinery and adaptations. Nat Cell Biol.
9:1102–1109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yang Z and Klionsky DJ: Mammalian
autophagy: core molecular machinery and signaling regulation. Curr
Opin Cell Biol. 22:124–131. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
He C and Klionsky DJ: Regulation
mechanisms and signaling pathways of autophagy. Annu Rev Genet.
43:67–93. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yang Z and Klionsky DJ: Eaten alive: a
history of macroautophagy. Nat Cell Biol. 12:814–822. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Frankel LB and Lund AH: MicroRNA
regulation of autophagy. Carcinogenesis. 33:2018–2025. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Fu LL, Wen X, Bao JK and Liu B:
MicroRNA-modulated autophagic signaling networks in cancer. Int J
Biochem Cell Biol. 44:733–736. 2012. View Article : Google Scholar : PubMed/NCBI
|
